ZNF473 cis-regulating long non-coding RNA (ZNF473CR)

ZNF473 cis-regulating long non-coding RNA (ZNF473CR, also known as FLJ26850) is a long non-coding RNA identified in human transcriptome analyses, notably in the context of congenital lung malformations[1][2]. As a lncRNA, it likely regulates gene expression in *cis*, potentially affecting the transcription of the adjacent ZNF473 gene, which encodes a zinc finger protein. lncRNAs of this type are often implicated in the regulation of transcription and may play roles in inflammatory and immune response pathways, as well as cell proliferation. Currently, ZNF473CR is not considered a direct therapeutic target such as a receptor, enzyme, or transporter, and there are no known interacting drugs or established biomarker or safety data. The target's existence is supported as an lncRNA with possible regulatory roles rather than as a canonical therapeutic target[1][2][4]. Clarifying notes: - This molecule is an **lncRNA** detected in transcriptomics studies, most notably associated with congenital lung malformations, and not a canonical drug target like a receptor or enzyme[1][2]. - The designation "ZNF473CR" is not standard in major databases; "FLJ26850" is the annotation used in transcriptomic research[1][2]. - There are no documented drugs, biomarkers, or specific therapeutic implications for this lncRNA at present. - While it may influence the *ZNF473* gene through *cis*-regulation, its therapeutic targeting or biomarker use is not established as of current knowledge. - There is some ambiguity or nonstandardization around its naming and characterization, so flagging **is_incorrect: true** for full target registry purposes is warranted.

Other names

FLJ26850ZNF473CR